Literature DB >> 19069637

Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy.

Grozdana Bilic1, Steffen M Zeisberger, Ajit S Mallik, Roland Zimmermann, Andreas H Zisch.   

Abstract

Emerging evidence suggests human amnion tissue as a valuable source of two distinct types of pluripotent cells, amnion epithelial cells (hAECs) and mesenchymal stromal cells (hAMSCs), for applications in cell replacement therapy. For some approaches, it may be necessary to culture and differentiate these cells before they can be transplanted. No systematic attempt has been yet made to determine the quantity and quality of amnion cells after isolation and culture. We looked at amnion cell isolates from 27 term placentas. Following our optimized protocol, primary yields were 6.3 x 10(6) hAECs and 1.7 x 10(6) hAMSCs per gram amnion. All 27 cases gave vital cultures of hAMSCs, while one third of cases (9 of 27) failed to give adherent cultures of hAECs. Primary cultures contained significantly more proliferating than apoptotic cells (hAECs: 16.4% vs. 4.0%; hAMSCs: 9.5% vs. 2.4%). Neither hAECs nor hAMSCs were clonogenic. They showed slow proliferation that almost stopped beyond passage 5. Microscopic follow-up revealed that hAEC morphology gradually changed towards mesenchymal phenotype over several passages. Flow cytometric characterization of primary cultures showed expression of mesenchymal progenitor markers CD73, CD90, CD105, and CD166, as well as the embryonic stem cell markers SSEA-3 and -4 on both amnion cell types. These profiles were grossly maintained in secondary cultures. Reverse transcriptase-PCR analysis exhibited transcripts of Oct-3/4 and stem cell factor in primary and secondary cultures of all cases, but no telomerase reverse transcriptase. Immunocytochemistry confirmed translation into Oct-3/4 protein in part of hAEC cultures, but not in hAMSCs. Further, both amnion cell types stained for CD90 and SSEA-4. Osteogenic induction studies with amnion cells from four cases showed significantly stronger differentiation of hAECs than hAMSCs; this capacity to differentiate greatly varied between cases. In conclusion, hAECs and hAMSCs in culture exhibit and maintain a similar marker profile of mesenchymal progenitors. hAECs were found as a less reliable source than hAMSCs and altered morphology during subculture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19069637     DOI: 10.3727/096368908786576507

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  54 in total

1.  Osteogenic differentiation of human amniotic epithelial cells and its application in alveolar defect restoration.

Authors:  Si Jiawen; Zhang Jianjun; Dai Jiewen; Yu Dedong; Yu Hongbo; Shi Jun; Wang Xudong; Steve G F Shen; Guo Lihe
Journal:  Stem Cells Transl Med       Date:  2014-11-03       Impact factor: 6.940

2.  Evaluation of the cell viability of human Wharton's jelly stem cells for use in cell therapy.

Authors:  Ingrid Garzón; Barbara Pérez-Köhler; Juan Garrido-Gómez; Victor Carriel; Renato Nieto-Aguilar; Miguel Angel Martín-Piedra; Natalio García-Honduvilla; Julia Buján; Antonio Campos; Miguel Alaminos
Journal:  Tissue Eng Part C Methods       Date:  2012-01-26       Impact factor: 3.056

3.  A Comparison of Culture Characteristics between Human Amniotic Mesenchymal Stem Cells and Dental Stem Cells.

Authors:  Nurul Hidayat Yusoff; Saaid Ayesh Alshehadat; Ahmad Azlina; Thirumulu Ponnuraj Kannan; Suzina Sheikh Abdul Hamid
Journal:  Trop Life Sci Res       Date:  2015-04

4.  Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro.

Authors:  H Karlsson; T Erkers; S Nava; S Ruhm; M Westgren; O Ringdén
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

5.  Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.

Authors:  Karen Bieback; Irena Brinkmann
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

Review 6.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

7.  Characterization of amniotic stem cells.

Authors:  Chika Koike; Kaixuan Zhou; Yuji Takeda; Moustafa Fathy; Motonori Okabe; Toshiko Yoshida; Yukio Nakamura; Yukio Kato; Toshio Nikaido
Journal:  Cell Reprogram       Date:  2014-08       Impact factor: 1.987

8.  Distinguishing characteristics of stem cells derived from different anatomical regions of human degenerated intervertebral discs.

Authors:  Hai Wang; Yue Zhou; Tong-Wei Chu; Chang-Qing Li; Jian Wang; Zheng-Feng Zhang; Bo Huang
Journal:  Eur Spine J       Date:  2016-03-16       Impact factor: 3.134

9.  Low-intensity pulsed ultrasound activates ERK1/2 and PI3K-Akt signalling pathways and promotes the proliferation of human amnion-derived mesenchymal stem cells.

Authors:  Li Ling; Tianqin Wei; Lianli He; Yaping Wang; Yan Wang; Xiushan Feng; Wenqian Zhang; Zhengai Xiong
Journal:  Cell Prolif       Date:  2017-09-22       Impact factor: 6.831

10.  Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factors.

Authors:  Wendy Fitzgerald; Nardhy Gomez-Lopez; Offer Erez; Roberto Romero; Leonid Margolis
Journal:  Am J Reprod Immunol       Date:  2018-05-04       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.